WELLGISTICS HEALTH INC. - COMMON STOCK

Wellgistics Health Annual Letter to Shareholders From the Office of the CEO March 2025

27 3月 2025 08:05:00 条件 Nasdaq GlobeNewswire

Wellgistics Health Achieves SOC 2 Type 1 Compliance, Strengthening Security for AI-Driven Pharmacy Solutions and Employer-Based Healthcare Models

18 3月 2025 07:40:00 条件 Nasdaq GlobeNewswire

Wellgistics Health, Inc. Announces Leadership Transition: Brian Norton Appointed as CEO Following Tim Canning’s Departure

04 3月 2025 17:18:00 条件 Nasdaq GlobeNewswire

Protega Pharmaceuticals collaborates with Wellgistics to support pharmacist education and increase patient access to the first and only FDA-approved abuse-deterrent immediate-release opioid, ROXYBOND™

04 3月 2025 07:40:00 条件 Nasdaq GlobeNewswire

Wellgistics Expands Healthcare Ecosystem with Tollo Health Agreement, Targeting Multi-Billion Dollar GLP-1 and Long COVID Market

26 2月 2025 07:40:00 条件 Nasdaq GlobeNewswire

Wellgistics Health, Inc. Announces Closing of $4.0 Million Initial Public Offering

24 2月 2025 16:05:00 条件 Nasdaq GlobeNewswire

Wellgistics Health, Inc. Announces Pricing of $4.0 Million Initial Public Offering

21 2月 2025 08:05:00 条件 Nasdaq GlobeNewswire